VRCA
Verrica Pharmaceuticals Inc
4.80$
+7.5%
vs. previous close
Closing price · As of: Sep 30, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 100.0% | 100.0% | 99.2% | 95.0% | 91.2% | 92.8% | 87.5% | 95.0% | 94.5% | 90.3% | |
| 96.9% | 95.4% | 11.2% | 13.5% | 14.4% | 19.7% | 76.6% | 85.2% | 85.6% | 64.0% | |
| 96.9% | 95.4% | 97.7% | 90.6% | 88.3% | 87.8% | 76.6% | 85.2% | 85.6% | 64.0% | |
| – | – | – | – | – | 0.0% | 1.1% | 5.4% | 0.1% | 11.5% | |
| – | – | – | – | – | – | -1.1% | 1.3% | 4.5% | 4.7% | |
| – | – | 0.3% | 3.2% | 6.7% | 4.9% | 8.7% | – | – | – | |
| 589.7% | 177.5% | 2.7% | 5.0% | 55.5% | 59.3% | 10.5% | 75.8% | 118.2% | 47.5% | |
| 77.0% | 6.8% | 2.7% | 4.9% | 53.2% | 57.5% | 7.7% | 20.9% | 53.6% | 34.9% | |
| 6.6% | 0.2% | – | 0.2% | 47.9% | 52.3% | 0.7% | 0.9% | 25.1% | 1.6% | |
| 18.9% | 1.8% | 1.0% | 1.7% | 0.5% | 1.1% | 1.1% | 3.0% | 3.5% | 4.4% | |
| – | – | – | – | 47.6% | – | – | 52.5% | 57.2% | – | |
| -489.7% | -77.5% | 97.3% | 95.0% | 44.5% | 40.7% | 89.5% | 24.2% | -18.2% | 52.5% | |
| -491.9% | -136.9% | -36.0% | -89.4% | -140.1% | -173.4% | -365.5% | -282.4% | -567.2% | -689.4% | |
| 472.4% | 28.3% | 2.7% | 3.6% | 3.4% | 3.4% | 7.6% | 5.6% | 9.6% | 22.6% |
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.